Hydralazine Hydrochloride Injection
Product Images NDC 51662-1388

6 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 51662-1388). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized Labeling (51662 1388 1 Serialized Labeling)

Serialized Labeling (51662 1388 1 Serialized Labeling)
A 1 mL single dose vial of Hydralazine Hydrochloride Injection, USP, with a strength of 20 mg/mL. The vial has a blue cap and a label indicating it is for intramuscular or intravenous use, Rx only. The vial is distributed by HF Acquisition Co LLC, DBA HealthFirst, with NDC 17478-934-01 and includes a barcode and manufacturing information.*
FDA Label Image

Vial Labeling (51662 1388 1 Vial Labeling)

Vial Labeling (51662 1388 1 Vial Labeling)
Label for Hydralazine Hydrochloride Injection, USP 20 mg/mL single-dose vial. The label states it is for intramuscular or intravenous use and includes storage instructions to keep between 20° to 25°C. Manufactured by Akorn, Inc., the label also shows the NDC 17478-934-01 and a barcode with spaces for lot and expiration dates.*
FDA Label Image

Adverse Reactions (Adverse Reactions)

Adverse Reactions (Adverse Reactions)
This text panel lists adverse reactions associated with a drug, categorized as common, less frequent, and other. It includes symptoms affecting various systems such as cardiovascular, respiratory, neurologic, genitourinary, hematologic, and hypersensitive reactions, describing specific side effects like headache, nausea, hypotension, rash, and conjunctivitis.*
FDA Label Image

How Supplied (How Supplied)

How Supplied (How Supplied)
Data table listing NDCs for single-dose vials of Hydralazine Hydrochloride injection, specifying package sizes of 10 and 25 vials per box. Each vial contains 1 mL.*
FDA Label Image

Overdosage (Overdosage)

Overdosage (Overdosage)
A text panel excerpt discussing acute toxicity of Hydralazine Hydrochloride injection. It states no deaths due to acute poisoning have been reported, cites the highest known dose survived in adults as 10 grams orally, and provides the oral LD50 values in rats as 173 and 187 mg/kg.*
FDA Label Image

Structure (Structure Discription)

Structure (Structure Discription)
Chemical structure of Hydralazine Hydrochloride showing a fused aromatic ring system bonded to a hydrazine group and associated with hydrochloride (HCl). The structure includes a benzene ring fused to a heterocyclic ring with nitrogen atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.